Pluvicto launch date?

When did Pluvicto (pluvicto) launch in the U.S.?

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) launched in the United States in 2021.

What was the first approval date that kicked off Pluvicto’s launch?

Pluvicto’s launch followed its FDA approval in March 2021, which made it available for eligible patients starting that year.

When did European access start?

European availability started around the time of EU approval in 2021, though the exact launch date can vary by country and reimbursement timing.

Why launch timing matters (and what to check next)

If you’re looking for a specific “launch date” tied to pricing, reimbursement, or uptake, the most accurate dates are usually:
- Regulatory approval date (start of marketing authorization)
- NDC/market launch in specific countries
- Coverage and reimbursement decisions (often later than approval)

If you tell me the region you mean (U.S., EU, UK, or another country), I can narrow it to the specific launch/first-availability date for that market.